Manual lymphatic drainage device for sleep apnea patients
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests if a nightly automated manual lymphatic drainage device called Neuroglide can improve how the brain clears waste (glymphatic function) in people with obstructive sleep apnea. You may qualify if you are 50 or older, have sleep apnea, and regularly use CPAP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You have obstructive sleep apnea.
- You have been using CPAP therapy consistently and effectively for at least 6 months.
- You are willing to use the Neuroglide device every night for one month and wear a sleep monitor at home.
- You are stable on any medications for other health conditions for at least 3 months and do not plan to change them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new nerve-stimulation therapy called Neuromod to treat moderate-to-severe sleep apnea in people who do not have access to other treatments. If you qualify, you would be part of a study to see if this implant helps improve your breathing during sleep.
This trial tests a device that stimulates a nerve to keep your airway open during sleep. It might help if you have moderate to severe obstructive sleep apnea and cannot use a CPAP mask.
This trial tests a device that uses mild electrical pulses to help keep your airway open while you sleep. It's for people with moderate sleep apnea who have trouble using a CPAP machine.
This study tests a new proactive therapy for people recently diagnosed with moderate or severe sleep apnea. It aims to see how well patients stick with the treatment outside of a sleep lab.
This trial tests if a new 3D scanning method can better fit a dental device (MAD) for people with mild to moderate obstructive sleep apnea (OSA). It may help those using a MAD get more effective treatment.
This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.